Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 518 across all filing types
Latest filing 2020-10-08 Regulatory Filings
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Rozpoczęcie badań prewalidacyjnych panelu PCR|ONE SARS-CoV-2 na próbkach klinicznych w zewnętrznym laboratorium szpitalnym - Content (PL)
Regulatory Filings Classification · 99% confidence The document is a short announcement (1674 characters) written in Polish, referencing previous current reports ('raport bieżący'). It details the commencement of pre-validation testing for a SARS-CoV-2 PCR panel by a subsidiary, including the purpose of the tests (comparison with existing systems) and the next steps (formal clinical trials for CE-IVD and FDA Emergency Use Authorization). This content relates to operational progress and regulatory pathways for a product, but it is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it is a specific operational update that doesn't fit the defined categories like M&A (TAR), Capital (CAP), or Director's Dealing (DIRS), and it is not merely announcing the publication of a report (RPA), it falls best under the general 'Regulatory Filings' category as a specific, non-standard announcement, or potentially 'LTR' if viewed as a regulatory progress update, but 'RNS' is the designated fallback for miscellaneous regulatory announcements.
2020-10-08 Polish
Uruchomienie linii produkcyjnej dla systemu BacterOMIC tj. samodzielne uruchomienie produkcji chipów oraz analizatorów w zakresie niezbędnym do przeprowadzenia badań przedrejestracyjnych - Content ...
Governance Information Classification · 85% confidence The document text is in Polish and describes the completion of a project milestone related to setting up production lines for assembling chips (cartridges) and devices (analyzers and fillers) according to the ISO 13485 standard. It details the equipment installed, the documentation created (BOMs, SOPs), and mentions an upcoming external certification audit planned for Q2 2021. This content relates to internal operational setup, quality systems (ISO 13485), and project execution, rather than standard periodic financial reporting (10-K, IR, ER) or shareholder communications (DEF 14A, AGM-R). Since it details internal operational progress and quality system documentation, it fits best under Governance Information (CGR) or potentially Regulatory Filings (RNS) if it's a mandatory project update. Given the focus on internal procedures, documentation standards (ISO 13485), and operational setup, CGR (Governance Information) is the most appropriate fit among the provided specific categories, as governance often encompasses quality management systems and operational compliance documentation.
2020-10-01 Polish
Decyzja w sprawie wprowadzenia Spółki na rynek regulowany GPW - Content (PL)
Share Issue/Capital Change Classification · 99% confidence The document is a formal announcement from the Management Board (Zarząd) of Scope Fluidics S.A. regarding their intention to list the company's shares on the regulated market of the Warsaw Stock Exchange (GPW) in 2021. It details the decision to conduct analyses to determine the optimal timing, scenarios, and conditions for this listing. This action relates directly to the company's capital structure and market listing strategy, which falls under financing activities or capital structure changes. Given the options, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it discusses plans for market listing and associated strategic considerations, rather than being a general regulatory filing (RNS) or a specific report.
2020-09-29 Polish
Podpisanie listu intencyjnego dotyczącego przygotowania mocy produkcyjnych na skalę umożliwiającą potencjalnemu nabywcy systemu PCR|ONE szybkie wejście na rynek diagnostyki molekularnej Point-of-Ca...
M&A Activity Classification · 92% confidence The document is a formal announcement in Polish (indicated by keywords like "W nawiązaniu do wcześniejszych raportów bieżących", "Zarząd", "Spółka", "List intencyjny") detailing a non-binding Letter of Intent signed between Scope Fluidics S.A. and two other entities regarding potential mass production of PCR cartridges and support in M&A transactions. This describes a significant corporate event related to strategic partnerships, production scaling, and potential M&A activity. Since it is an announcement about a strategic development that involves potential M&A support and production scaling, it fits best under the category of M&A Activity (TAR) or a general Regulatory Filing (RNS). Given the explicit mention of supporting an M&A transaction ("wspierać Spółkę w procesie transakcji M&A"), TAR is the most specific fit, although it is not a formal takeover bid document itself. However, since the core of the announcement is about establishing a framework for future cooperation that explicitly mentions M&A support, and it is a material corporate event announcement, TAR (M&A Activity) is the most appropriate classification among the specific options, as it relates directly to strategic corporate transactions. If TAR is too narrow, RNS would be the fallback. Given the context of M&A support being a key component, I will select TAR.
2020-09-28 Polish
Informacja dotycząca aktualnego etapu rozwoju systemu PCR|ONE i systemu BacterOMIC - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal update from the Management Board ('Zarząd') of Scope Fluidics S.A. regarding the progress of two development projects (PCR|ONE and BacterOMIC), including timelines for clinical testing, regulatory submissions (to the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products - 'Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych'), and expected certification dates (CE-IVD, FDA EUA). This content details operational and strategic progress, which falls under the scope of Management's explanation of business trends and outlook, rather than being a full financial report (10-K or IR) or a simple announcement of a report release (RPA). It is a detailed update on business activities and progress towards product certification. This aligns best with the Management Reports (MDA) definition, which covers detailed explanations of business trends and outlook.
2020-09-21 Polish
Podpisanie umowy finansowania z Europejskim Bankiem Inwestycyjnym - Content (PL)
Capital/Financing Update Classification · 98% confidence The document text details the signing of a financing agreement ("Umowa Finansowania") between Scope Fluidics S.A. and the European Investment Bank for up to 10 million EUR. It outlines the terms, tranches, interest rates, warrants, and conditions for disbursement related to this debt financing. This content directly relates to the company's fundraising and capital structure activities, which aligns perfectly with the definition of 'Capital/Financing Update'. The document is a substantive report detailing the terms of the financing, not merely an announcement that a report has been published (which would suggest RPA or RNS).
2020-09-07 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.